Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 415.55
+3.05 (0.74%)
Aug 21, 2026, 3:14 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 672.99 billion as of August 21, 2026. Its market cap has increased by 40.30% in one year.
Market Cap
672.99B
Enterprise Value
814.39B
Revenue
173.21B
Ranking
n/a
PE Ratio
123.42
Stock Price
415.55
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 672.99B, an increase of 1,381.92%. That is a compound annual growth rate of 12.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 672.99B | 28.03% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 492.51B |
| OneSource Specialty Pharma | 174.32B |
| Concord Biotech | 164.95B |
| Blue Jet Healthcare | 112.11B |
| Supriya Lifescience | 65.33B |
| Zota Health Care | 37.29B |
| Dishman Carbogen Amcis | 27.03B |
| Panacea Biotec | 25.34B |